Delivering the Added Dimension in Drug Discovery Services
Biosys Computational Chemistry team excels in
drug discovery design efforts in collaboration with the medicinal chemistry,
biology and DMPK teams, by conducting molecular modeling studies – ligand-based
drug design approaches (LBDD, pharmacophore and QSAR modeling), protein
structure-based drug design (SBDD, homology modeling, docking and
scoring), fragment-based drug design, chemoinformatic analysis and de novo
The team providing these computational chemistry services extensively utilizes in-house expertise in software development, curation and structural biology for driving molecular design.
The Jubilant modeling group is actively involved in over twenty integrated drug discovery projects and modeling collaborations
Molecular modeling (structure-based drug design) techniques have been employed in the development of two clinical candidates (GPCR and kinase targets) and a backup candidate (protease target) for clinical trials
Jubilant’s computational chemistry group played a critical role in the design and successful development of a multi-kinase inhibitor series for two different projects
Molecular Design Collaborations
Our team of computational chemists empowers drug discovery scientists to deploy ready-to-use models and make faster and wiser decisions.
The Tools Used for Computational Drug Discovery
Jubilant proprietary platforms for drug properties and shape-based searches
Extensive databases of drugs and leads from the literature
Curated small molecule databases containing over 2 million molecules, covering all therapeutically significant target classes: kinases, GPCRs, ion channels, NHRs, PDEs, proteases and a known drug database.
Schrodinger molecular modeling and CIMPL chemoinformatics software platforms
Scaffold, bio-isostere and R-group databases
Multi-core, high-performance workstation with GPU card for molecular dynamics, virtual screening and quantum calculations
Internal software tools to facilitate the execution of complex modeling tasks
The People Providing Expertise in a Range of Computational Chemistry Solutions
A strong and highly diverse modeling team, proficient in all relevant aspects of drug design
Leadership with versatile skills in modeling, experienced in the development of drug candidates and marketed drugs
Management with over thirty years of combined pharmaceutical industry experience
Senior leaders with a strong publication and patent record, covering diverse therapeutic targets and computational methodologies
Can we have some information?
Please fill out our short form in order to activate your download.
Thank you. Please click the button to start your download.